HEALTHSTAT NEWS
STAT+: Swing Therapeutics acquired by medical VR platform XR Health
Swing Therapeutics, developer of an FDA-cleared digital treatment for fibromyalgia, was acquired by XR Health, a medical VR platform. XR Health, which has made six acquisitions in two years, aims to expand its platform of digital treatments, offering VR-based solutions for mental health, pain, and other conditions. The acquisition terms were undisclosed, as XR Health CEO Eran Orr indicated the company will continue acquiring treatments.
Mentioned
Related Signal
Adjacent reporting
- STAT+: Pharmalittle: We’re reading about a Lilly gene therapy for cholesterol, three new Lilly deals, and more
- STAT+: Pharmalittle: We’re reading about a $10.6 billion GSK deal, an AstraZeneca obesity pill, and more
- STAT+: Pharmalittle: We’re reading about a $10 billion Vertex deal, the pace of FDA drug approvals, and more
- STAT+: Angelini Pharma buys Catalyst Pharmaceuticals and its rare disease drugs for $4.1B
- Roundup: Fed report / Air taxis / $7B healthcare acquisition